@article{8f376a9b895d4fe988098a7e8eed055d,
title = "Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control",
abstract = "In 108 households (n = 474, 280 ≤ 18 years old), SARS-CoV-2 seroprevalence was significantly associated with age (range 37.5%-78.7%) and lowest in children ≤ 10 years old. Among 92 households with members ≤ 18, 14 (15.2%) had only a seropositive child or adolescent, while 16 (17.4%) had only seropositive adults. Households with both groups concurrently seropositive (n = 62) were larger in size (mean 8.11 ± 2.49) vs (mean 5.77 ± 2.31) (P <.001).",
keywords = "COVID-19, Children, Household",
author = "Alan Werzberger and Carre{\~n}o, {Juan Manuel} and Team, {Sinai Serocore} and Adam Polinger and Florian Krammer and Philip Zachariah",
note = "Funding Information: Funding/Support: Work in the Krammer laboratory for this study was mainly funded directly by the Ezras Choilim Health Center . Work was partially funded by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051 , NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C and HHSN272201400006C ), NIAID grants U01AI141990 and U01AI150747 , by the generous support of the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611 (5384) , and by anonymous donors. This project was also funded in part with federal funds from the National Cancer Institute, National Institutes of Health , under contract 75N91019D00024 , task order 75N91020F00003 . The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. Funding Information: Funding/Support: Work in the Krammer laboratory for this study was mainly funded directly by the Ezras Choilim Health Center. Work was partially funded by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C and HHSN272201400006C), NIAID grants U01AI141990 and U01AI150747, by the generous support of the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611 (5384), and by anonymous donors. This project was also funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract 75N91019D00024, task order 75N91020F00003. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. Publisher Copyright: {\textcopyright} 2021 Association for Professionals in Infection Control and Epidemiology, Inc.",
year = "2021",
month = nov,
doi = "10.1016/j.ajic.2021.08.015",
language = "English",
volume = "49",
pages = "1438--1440",
journal = "American Journal of Infection Control",
issn = "0196-6553",
publisher = "Mosby Inc.",
number = "11",
}